ArticleBlood cancer journal2019

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.

Timothy M Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.